• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Crotamiton

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph. Eur. monograph 1194)

bp2013_v1_07_medicinal_and_pharmaceutical_substances_05 crotamiton_1_2012_70_cs.png


C13H17NO    203.3    483-63-6

Action and use

Acaricide.

Preparations

Crotamiton Cream

Crotamiton Lotion

Ph Eur

DEFINITION

N-Ethyl-N-(2-methylphenyl)but-2-enamide.

Content:
  • sum of the (E)- and (Z)-isomers: 96.0 per cent to 102.0 per cent;
  • — (Z)-isomer: maximum 15.0 per cent.
CHARACTERS
Appearance

Colourless or pale yellow, oily liquid.

Solubility

Slightly soluble in water, miscible with ethanol (96 per cent).

At low temperatures it may partly or completely solidify.

IDENTIFICATION

First identification   B.

Second identification   A, C, D.

A. Ultraviolet and visible absorption spectrophotometry (2.2.25).

Test solution  Dissolve 25.0 mg in cyclohexane R and dilute to 100.0 mL with the same solvent. Dilute 1.0 mL of this solution to 10.0 mL with cyclohexane R.

Spectral range  220-300 nm.

Absorption maximum  At 242 nm.

Specific absorbance at the absorption maximum  300 to 330.

B. Infrared absorption spectrophotometry (2.2.24).

Comparison  crotamiton CRS.

C. Thin-layer chromatography (2.2.27).

Test solution  Dissolve 25 mg of the substance to be examined in anhydrous ethanol R and dilute to 10 mL with the same solvent.

Reference solution  Dissolve 25 mg of crotamiton CRS in anhydrous ethanol R and dilute to 10 mL with the same solvent.

Plate  TLC silica gel F254 plate R.

Mobile phase  Shake 98 volumes of methylene chloride R with 2 volumes of concentrated ammonia R, dry over anhydrous sodium sulfate R, filter and mix 97 volumes of the filtrate with 3 volumes of 2-propanol R.

Application  5 µL.

Development  Over a 2/3 of the plate.

Drying  In air.

Detection  Examine in ultraviolet light at 254 nm.

Results  The principal spot in the chromatogram obtained with the test solution is similar in position and size to the principal spot in the chromatogram obtained with the reference solution.

D. To 10 mL of a saturated solution add a few drops of a 3 g/L solution of potassium permanganate R. A brown colour is produced and a brown precipitate is formed on standing.

TESTS
Relative density (2.2.5)

1.006 to 1.011.

Refractive index (2.2.6)

1.540 to 1.542.

Free amines

Maximum 500 ppm, expressed as ethylaminotoluene.

Dissolve 5.00 g in 16 mL of methylene chloride R and add 4.0 mL of glacial acetic acid R. Add 0.1 mL of metanil yellow solution R and 1.0 mL of 0.02 M perchloric acid. The solution is red-violet.

Maximum 100 ppm.

Boil 5.0 g under a reflux condenser for 1 h with 25 mL of ethanol (96 per cent) R and 5 mL of a 200 g/L solution of sodium hydroxide R. Cool, add 5 mL of water R and shake with 25 mL of ether R. Dilute the lower layer to 20 mL with water R; add 5 mL of nitric acid R, dilute to 50 mL with water R and add 1 mL of a freshly prepared 50 g/L solution of silver nitrate R. Any opalescence in the solution is not more intense than that in a mixture of 1 mL of a freshly prepared 50 g/L solution of silver nitrate R and a solution prepared by diluting 5 mL of a 200 g/L solution of sodium hydroxide R to 20 mL with water R and adding 1.5 mL of 0.01 M hydrochloric acid, 5 mL of nitric acid R and diluting to 50 mL with water R.

Related substances

Liquid chromatography (2.2.29).

Test solution (a)  Dissolve 50.0 mg of the substance to be examined in the mobile phase and dilute to 100.0 mL with the mobile phase.

Test solution (b)  Dilute 1.0 mL of test solution (a) to 20.0 mL with the mobile phase.

Reference solution (a)  Dissolve 50.0 mg of crotamiton CRS in the mobile phase and dilute to 100.0 mL with the mobile phase. Dilute 1.0 mL of this solution to 20.0 mL with the mobile phase.

Reference solution (b)  Dissolve 15.0 mg of crotamiton impurity A CRS in the mobile phase and dilute to 20.0 mL with the mobile phase. Dilute 1.0 mL of this solution to 50.0 mL with the mobile phase.

Reference solution (c)  Dilute 1.0 mL of test solution (a) to 100.0 mL with the mobile phase.

Reference solution (d)  Dissolve 15 mg of crotamiton impurity A CRS in the mobile phase and dilute to 100.0 mL with the mobile phase. Dilute 1.0 mL of this solution to 10.0 mL with test solution (a).

Column:
  • size: l = 0.25 m, Ø = 4 mm;

Mobile phase  tetrahydrofuran R, cyclohexane R (8:92 V/V).

Flow rate  1.0 mL/min.

Detection  Spectrophotometer at 242 nm.

Injection  20 µL of test solution (a) and reference solutions (b), (c) and (d).

Run time  2.5 times the retention time of the (E)-isomer.

Relative retention  With reference to the (E)-isomer: (Z)-isomer = about 0.5; impurity A = about 0.8.

System suitability  Reference solution (d):

  • resolution: minimum 4.5 between the peaks due to impurity A and the (E)-isomer.
Limits:
  • impurity A: not more than the area of the corresponding peak in the chromatogram obtained with reference solution (b) (3.0 per cent);
  • unspecified impurities: for each impurity, not more than 0.1 times the sum of the areas of the peaks due to the (Z)- and (E)- isomers in the chromatogram obtained with reference solution (c) (0.10 per cent);
  • sum of impurities other than A: not more than the sum of the areas of the peaks due to the (Z)- and (E)-isomers in the chromatogram obtained with reference solution (c) (1.0 per cent);
  • disregard limit: 0.02 times the sum of the areas of the peaks due to the (Z)- and (E)-isomers in the chromatogram obtained with reference solution (c) (0.02 per cent).
Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Liquid chromatography (2.2.29) as described in the test for related substances with the following modification.

Injection  Test solution (b) and reference solution (a).

Calculate the percentage content of C13H17NO from the sum of the areas of the peaks due to the (Z)- and (E)-isomers in the chromatograms obtained. Calculate the content of the (Z)-isomer, as a percentage of the total content of the (E)- and (Z)-isomers, from the chromatogram obtained with test solution (b).

STORAGE

Protected from light.

IMPURITIES

Specified impurities   A.

bp2013_v1_07_medicinal_and_pharmaceutical_substances_05 crotamiton_2_2012_70_cs.png


A. N-ethyl-N-(2-methylphenyl)but-3-enamide.

Ph Eur